ZIM LABORATORIES
Back to Balance Sheet
|
ZIM LABORATORIES Last 5 Year Total Non-Current Liabilities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Total Non-Current Liabilities | ₹52 Cr | ₹53 Cr | ₹49 Cr | ₹30 Cr | ₹20 Cr |
What is the latest Total Non-Current Liabilities ratio of ZIM LABORATORIES ?
| Year | Total Non-Current Liabilities |
|---|---|
| Mar2026 | ₹52 Cr |
| Mar2025 | ₹53 Cr |
| Mar2024 | ₹49 Cr |
| Mar2023 | ₹30 Cr |
| Mar2022 | ₹20 Cr |
How is Total Non-Current Liabilities of ZIM LABORATORIES Trending?
| Years | Total Non-Current Liabilities | % Change | |
|---|---|---|---|
| Mar2026 | ₹52 Cr | -1.95 | |
| Mar2025 | ₹53 Cr | 9.80 | |
| Mar2024 | ₹49 Cr | 59.79 | |
| Mar2023 | ₹30 Cr | 52.16 | |
| Mar2022 | ₹20 Cr | - | |
Compare Total Non-Current Liabilities of peers of ZIM LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| ZIM LABORATORIES | ₹670.2 Cr | -0.2% | 10.3% | 66.2% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹455,994.0 Cr | -0% | -4.5% | 15.9% | Stock Analytics | |
| DIVIS LABORATORIES | ₹240,249.0 Cr | 5.9% | 16.1% | 49.6% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹191,135.0 Cr | 3% | 3% | 34% | Stock Analytics | |
| CIPLA | ₹114,708.0 Cr | -0.4% | -3.6% | -11.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹98,074.9 Cr | NA | 2.8% | -7.1% | Stock Analytics | |
ZIM LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| ZIM LABORATORIES | -0.2% |
10.3% |
66.2% |
| SENSEX | -0.8% |
0.2% |
-6% |
You may also like the below Video Courses